Search Results
) 3. McKay B , Josephson A : Pregnancy after kidney transplantation . Clin J Am Soc Nephrol 3 Suppl 2 , S117 – 125 ( 2008 ) 4
Col, V. J., Jacquet, L., Squifflet, J. P. és mtsai: Combined heart-kidney transplantation: report on six cases. Nephrol. Dial. Transplant., 1998, 13 , 723
. 5. S. Sarkio 2004 Severe gastrointestinal complications after 1,515 adult kidney transplantations Transpl Int
Süsal, C., Roelen, D. L., Fischer, G., et al.: Algorithms for the determination of unacceptable HLA antigen mismatches in kidney transplant recipients. Tissue Antigens, 2013, 82 (2), 83
OB , Scheltinga MR , Stubenitsky BM , Kootstra G : Horseshoe kidney transplantation: an overview . Clin Transplant 14 , 515 – 519 ( 2000 ) 10. Marofka
J.P. Soulillou M. Giral-Classe 2004 Ureteral necrosis after kidney transplantation: Risk factors and impact on graft and patient survival
J. Urol. 1974 111 145 147 Hume, D. M.: Kidney Transplantation. In
Aull-Watschinger, S., Konstantin, H., Demetriou, D. és mtsai: Pre-transplant predictors of cerebrovascular events after kidney transplantation. Nephrol. Dial. Transplant., 2008, 23 , 1429–1435. Demetriou D
Obesity and hyperlipidaemia are found very frequently after kidney transplantation (Tx) and may represent independent risk factors for development of atherosclerosis and chronic allograft nephropathy. In a prospective metabolic study, we monitored, a total of 68 obese transplant patients [body mass index (BMI)> 30 kg/m 2 ] with dyslipidaemia over a period of 24 months. We compared the findings of a new therapeutic regimen 1 year (start of the study) and 2 years after renal transplantation. Based on a Subjective Global Assessment Scoring Sheet, we started at the end of the first year with an individualized hypoenergic-hypolipidaemic diet (IHHD). Subsequently, after corticoid withdrawal, IHHD was supplemented regularly with statins (atorvastatin 10–20 mg/day)) and followed-up for 2 years. All patients were on a regimen of cyclosporin A or tacrolimus and mycophenolate mofetil. During the study period, there was a significant decrease in BMI (p<0.025) and an increase of the adiponectin level (p<0.01). Long-term therapy was associated with a significant decrease in serum leptin (p<0.01) and lipid metabolism parameters (p<0.01). Insulin clearance, mean systolic and diastolic blood pressure, proteinuria, lipoprotein(a) and apo-lipoprotein E isoforms did not differ significantly.Based on our results, we assume that obesity and hyperlipidaemia after renal transplantation can be treated effectively by modified immunosuppression (corticosteroid withdrawal), statins and long-term diet (IHHD). The increased level of adiponectin may be a marker of reducing atherosclerotic and chronic allograft nephropathy processes.
Perner, F., Megyaszai, S., Járay, J., et al.: Successful kidney transplantation in Hungary. [Sikeres veseátültetés hazánkban.] Orv. Hetil., 1974, 115 , 2067–2068. [Hungarian] Járay J
